Analysis of oncogenes and tumor-suppressor genes in oral cancers and the application to diagnosis

口腔癌癌基因和抑癌基因分析及其在诊断中的应用

基本信息

项目摘要

Human cancers emerge from a normal cell after multiple genetic changes of protooncogenes and tumor suppressor genes by multistep process. In the present research we focused on squamous cell carcinomas (SCC) in the oral cavity and examined abnormalities of ras and erbB1 (EGFR) protooncogenes, and p53 tumor suppressor gene.ras mutation : 29 tumor lesions of oral SCC were examined for the activational mutations of codons 12, 13, and 61 of N-, H- K-ras genes. Mutations were detected by hybridization of PCR (polymerase chain reaction)-amplified DNA with allele specific oligonucleotide probes or by PCR-SSCP (single strand conformation polymorphysm) analysis. As a result we could not detect mutation except for two cell lines which had mutations of codons 12 (HOC313) and 13 (ZA) of H-ras. Analysis of parafin-embedded sections showed that the tumor sample of HOC313 had the mutation at the time of initial diagnosis. Although the mutation of ZA was detected in the tumor tissue used for the cell l … More ine establishment, the normal epithelium and leukoplakia lesion were negative. From these results frequency of ras mutation in oral SCC is considerablly low compared with those of adenomas, thus suggesting that ras mutation may not important in tumorigenesis of oral SCC.p53 gene mutation : 15 oral SCC cell lines were examined for the presence of the mutation by cDNA-SSCP and exon-SSCP anlaysis, followed by direct sequencing. As a result, p53 gene mutations were found in 14 cell lines and were localized from cadon 126 to cadon 305. Two mutational hot-spots were found in codon 248 (3 cases) and the spliincg donor sequence of exon 6 (2 cases). Thirteen out of 14 mutations were point mutations including 10 missense mutations.Analysis of EGFR : increased capacity for EGF binding was observed in all the examined 4 cases of oral SCC.From these results it is anticipated that p53 gone mutations and increased capacity for EGF binding play important roles in the genesis of oral SCC, thus suggesting that both will be good diagnostic markers for SCC. Less
人类肿瘤是在原癌基因和抑癌基因的多个基因突变后,通过多步过程从正常细胞中产生的。本研究以口腔鳞状细胞癌为研究对象,检测了ras、ErbB1(EGFR)原癌基因和p53抑癌基因的异常。ras突变:检测了29例口腔鳞癌组织中N-、H-K-ras基因第12、13和61密码子的激活突变。用聚合酶链式反应扩增的DNA与等位基因特异的寡核苷酸探针杂交或单链构象多态分析检测突变。结果除两株H-ras基因密码子12(HOC313)和13(Za)发生突变外,未检测到突变。石蜡包埋切片分析表明,HOC313的肿瘤标本在最初诊断时已发生突变。虽然在用于L…细胞的肿瘤组织中检测到ZA突变正常上皮和白斑病变多为阴性。结果表明,口腔鳞癌组织中ras基因突变的发生率明显低于腺瘤组织,提示ras基因突变在口腔鳞状细胞癌的发生发展中可能不起重要作用。结果在14个细胞系中发现了p53基因突变,并定位于从Cadon 126到Cadon 305。在248密码子(3例)和外显子6的剪接供体序列(2例)中发现了两个突变热点。14个突变中有13个是点突变,其中10个是错义突变。EGFR分析:4例口腔鳞状细胞癌中均发现EGF结合量增加。从这些结果可以推测,P53基因突变和EGF结合量增加在口腔鳞癌的发生中起重要作用,提示两者都将是诊断口腔鳞癌的良好标记物。较少

项目成果

期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
E.Hara,T.Ohshima,T.Ishii W.Sugino,K.Tsutsui,S.Nakada,N.Tsuchida,and K.Oda: "Mechanism of induction of cellular DNA synthesis by the adenovirus E1A 12S cDNa product." Exp.Cell Res.,.
E.Hara、T.Ohshima、T.Ishii W.Sugino、K.Ttsutsui、S.Nakada、N.Tsuchida 和 K.Oda:“腺病毒 E1A 12S cDNA 产物诱导细胞 DNA 合成的机制”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
上田 晶義: "口腔腫瘍における癌遺伝子の解析 Studies an oncogenes in human oral tumors" 日本口腔外科学会雑誌. 36. 2211-2225 (1990)
Akiyoshi Ueda:“研究人类口腔肿瘤中的癌基因”日本口腔颌面外科学会杂志 36. 2211-2225 (1990)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tadokoro,K.,Ueda,M.,Ohshima,T.,Fujita,K.,Rikimaru,K.,Takahashi,N.,Enomoto,S.,and Tsuchida,N.: "Activation of onecogenes in human oral cancer cells:a novel codon 13 mutation of cーHーrasー1 and concurnent amplifieations of cーerbBー1 and cーmyc" Oncogene. 4. 499
Tadokoro, K.、Ueda, M.、Ohshima, T.、Fujita, K.、Rikimaru, K.、Takahashi, N.、Enomoto, S. 和 Tsuchida, N.:“人口腔癌细胞中 onecogenes 的激活4.499
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
E.Hara,T.Ohshima,T.Ishii,W.Sugino,K.Tsutsui,S.Nakada,N.Tsuchida,and K.oda: "Mechanism of induction of ceilular DNA synthesis by the adenovirus EIA 12S cDNA product." Exp.Cell Res.,. ((1992))
E.Hara、T.Ohshima、T.Ishii、W.Sugino、K.Ttsutsui、S.Nakada、N.Tsuchida 和 K.oda:“腺病毒 EIA 12S cDNA 产物诱导细胞 DNA 合成的机制”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大島 朋子: "ヒト骨肉腫細胞における癌抑制遺伝子の関与" 口腔病学会雑誌. 58(1). 310-328 (1991)
Tomoko Oshima:“人类骨肉瘤细胞中肿瘤抑制基因的参与”口腔医学会杂志 58(1)310-328(1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUCHIDA Nobuo其他文献

TSUCHIDA Nobuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUCHIDA Nobuo', 18)}}的其他基金

Abnormalities of structure, function, expression, and signal transduction of ERK in relation to carcinogenesis
ERK结构、功能、表达和信号转导异常与癌变相关
  • 批准号:
    16390520
  • 财政年份:
    2004
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Aberrant cell growth signaling in oral cancer
口腔癌中的异常细胞生长信号
  • 批准号:
    14370579
  • 财政年份:
    2002
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Alterations of ERK gene and the signal transduction pathway in oral squamous cell carcinoma and the roles in the genesis of the cancer
口腔鳞癌中ERK基因及信号转导通路的改变及其在癌症发生中的作用
  • 批准号:
    12470381
  • 财政年份:
    2000
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic alterations in cancers of digestive tract as analyzed by CGH, in relation to genesis of cancer and the metastasis.
通过 CGH 分析消化道癌症的遗传改变与癌症发生和转移的关系。
  • 批准号:
    10670492
  • 财政年份:
    1998
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles of p53 and ras gene mutations in genesis of oral SCC in India
p53 和 ras 基因突变在印度口腔鳞状细胞癌发生中的作用
  • 批准号:
    06044072
  • 财政年份:
    1994
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Molecular diagnosis of oral cancer based on aberrant expression and structural alterations of the p53 tumor suppressor gene
基于p53抑癌基因异常表达和结构改变的口腔癌分子诊断
  • 批准号:
    03557075
  • 财政年份:
    1991
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
In vitro differentiation of human osteosarcoma cells
人骨肉瘤细胞的体外分化
  • 批准号:
    62480374
  • 财政年份:
    1987
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

大豆MYB(v-myb avian myeloblastosis viral oncogene homolog)转录因子基因对大豆异黄酮合成调控的研究
  • 批准号:
    31371641
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目

相似海外基金

Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
  • 批准号:
    10090714
  • 财政年份:
    2024
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Collaborative R&D
Targeting MCPyV oncogene transcription to suppress tumorigenesis
靶向 MCPyV 癌基因转录抑制肿瘤发生
  • 批准号:
    10753259
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Driver Oncogene変異と子宮頸がんの標的療法の開発
驱动癌基因突变与宫颈癌靶向治疗的发展
  • 批准号:
    23K08854
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
癌基因激活线粒体未折叠蛋白反应调节衰老生物学
  • 批准号:
    10598922
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Investigation of the oncogenic mechanism of novel oncogene SETDB1 in gastrointestinal cancer
新癌基因SETDB1在胃肠道癌中的致癌机制研究
  • 批准号:
    23K08116
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathways of oncogene-induced senescence at DNA replication forks
癌基因诱导 DNA 复制叉衰老的途径
  • 批准号:
    10603686
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
The Phosphatase PRL3 as a MYC Target and Pro-Survival Oncogene in Acute Lymphoblastic Leukemia
磷酸酶 PRL3 作为急性淋巴细胞白血病的 MYC 靶点和促生存癌基因
  • 批准号:
    10527104
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
靶向微环境/癌基因合作治疗预后不良的 T-ALL
  • 批准号:
    10659661
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Immune control of oncogene selection in preneoplastic colon
癌前结肠癌基因选择的免疫控制
  • 批准号:
    10740144
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Targeting AVIL, a novel oncogene in rhabdomyosarcoma
针对横纹肌肉瘤中的一种新型癌基因 AVIL
  • 批准号:
    10585061
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了